Education Center

Advanced Renal Cell Carcinoma: A Treatment Option for Patients Who Have Received Prior Anti-Angiogenic Therapy


 

Renal cell carcinoma (RCC) is the most common form of kidney cancer. In this supplement to Federal Practitioner , read an expert's review of a treatment option for advanced RCC.

Click here to read the supplement.

 

Deepak Kilari, MD
Assistant Professor of Medicine
Medical College of Wisconsin
Clement J. Zablocki Veterans Affairs Medical Center
Milwaukee, Wisconsin

 

9/17 CA-0557

Next Article: